ENDRA Life Sciences Inc. (NDRA) — Financial statements
Income statement, balance sheet, and cash flow for ENDRA Life Sciences Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00↓100.0% | 0.28↑17.6% | 0.23↑4.4% | 0.22 | |
| Gross Profit | 0.00 | 0.00↑100.0% | -0.28↓17.6% | -0.23↓4.4% | -0.22 | |
| Operating Expenses | ||||||
| R&D Expenses | 2↓42.0% | 3↓36.2% | 5↓23.7% | 7↑19.5% | 5 | |
| General & Administrative Expenses | 4↓47.2% | 7 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.19↓66.8% | 0.57 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 4↓48.7% | 8↑45.5% | 5↓17.7% | 6↑10.0% | 6 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 6↓46.7% | 11↑5.6% | 10↓20.7% | 13↑14.6% | 11 | |
| Total Costs & Expenses | 6↓46.7% | 11↑2.8% | 11↓20.0% | 13↑14.4% | 11 | |
| Operating Results | ||||||
| Operating Income | -6↑46.7% | -11↓2.8% | -11↑20.0% | -13↓14.4% | -11 | |
| Depreciation & Amortization | 0.16↑238.3% | 0.05↓83.1% | 0.28↑17.6% | 0.23↑4.4% | 0.22 | |
| EBITDA | -6↑48.0% | -11↓10.1% | -10↑24.4% | -13↓17.6% | -11 | |
| EBIT | -6↑46.7% | -11↓7.5% | -10↑23.7% | -13↓17.3% | -11 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00 | 0.00 | 0.00↑100.0% | -0.02 | 0.00 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 0.02 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00↑100.0% | -0.46↓2238.8% | 0.02↑108.1% | -0.27 | |
| Other Income / Expenses | -1↓83.0% | -0.69↓250.0% | 0.46↑2238.5% | -0.02↓108.1% | 0.27 | |
| Income Before Tax | -7↑38.9% | -12↓14.4% | -10↑23.7% | -13↓17.3% | -11 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -7↑38.9% | -12↓14.4% | -10↑23.7% | -13↓17.3% | -11 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -7↑38.9% | -12↓14.4% | -10↑23.7% | -13↓17.3% | -11 | |
| Bottom-Line Net Income | -7↑38.9% | -12↓14.4% | -10↑23.7% | -13↓16.1% | -11 | |
| EPS (Basic) | -8.93↑12.9% | -10.25↓74.0% | -5.89↓28.9% | -4.57↑16.5% | -5.47 | |
| EPS (Diluted) | -8.93↑12.9% | -10.25↓74.0% | -5.89↑13.9% | -6.84↓25.0% | -5.47 | |
| Weighted Average Shares | 0.79↓29.9% | 1↓34.3% | 2↓11.5% | 2↓5.7% | 2 | |
| Weighted Average Diluted Shares | 0.79↓29.9% | 1↓34.3% | 2↓11.5% | 2↓5.7% | 2 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.